HMGB1 and cancer: Cisplatin treatment causes increased HMGB1 concentration in the nucleus (Figure 7A), and cancer cells seem to partially survive treatment with cisplatin by transporting HMGB1 from the nucleus into the cytosol where it is then secreted into the extracellular milieu.